
Impact of Reduced Fluoroquinolone Use on Clostridioides difficile Infections Resulting From the Fluoroquinolone-Resistant Ribotype 027 Strain in a Veterans Affairs Medical Center
Author(s) -
Sarah Redmond,
Sandra Y. Silva,
Brigid Wilson,
Jennifer L. Cadnum,
Curtis J. Donskey
Publication year - 2019
Publication title -
pathogens and immunity
Language(s) - English
Resource type - Journals
ISSN - 2469-2964
DOI - 10.20411/pai.v4i2.327
Subject(s) - clostridioides , veterans affairs , strain (injury) , clostridium difficile , medicine , microbiology and biotechnology , biology , antibiotics
Fluoroquinolone restriction has been proposed as a control measure for Clostridioides difficile infection (CDI) outbreaks associated with fluoroquinolone-resistant ribotype 027 strains. However, relatively few reports of fluoroquinolone restriction interventions have evaluated the impact on C. difficile strain types and fluoroquinolone resistance.